MacroGenics(美國)

MacroGenics

美國MacroGenicswww.macrogenics.com MACROGENICS是美國的生物技術(shù)制藥公司，擁有癌癥以及炎癥性疾病的抗體治療多個技術(shù)平臺,其中4個創(chuàng)新藥物已經(jīng)進入臨床研究，并已與美國的輝瑞（Pfizer），德國的勃林格殷格翰（Boehringer-Ingelheim）等國際企業(yè)建立了長期合作的關(guān)系。Sinceitsfoundingin2000,MacroGenicshasfo cusedonapplyingitsworld-classantibodycapabilitiestodiscover,developanddelivertopatientsnovelbiologicsforthetreatmentofcancer,autoimmunedisordersandinfectiousdiseases.Ourteamof135dedicatedindividualsiscommittedtoapplybreakthroughsciencetocreatelife-changingmedicines.Asanexample,ourleadautoimmuneproductcandidate,teplizumab,isthoughttoreprogramtheimmunesystemtore-establishthelostimmunebalancethatoccursinautoimmunediseasessuchastype1diabetes.Ifsuccessful,thisapproachwouldrepresentaparadigmshiftinthemanagementofadiseaseforwhichtherehasbeennonewtreatmentsincetheintroductionofinsulininthe1920’s.Ourinnovativeproductcandidatesl